2024-518419-20-00RecruitingPhase 2
New Beacon
Source: EU CTIS (euclinicaltrials.eu) · Last updated 23 Oct 2024 · Not updated for over 12 months - ask the site whether it is still open
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 53 (estimated)
- First submitted
- 27 Sept 2024
- Start date
- 23 Oct 2024
- Lead sponsor
- Rigshospitalet
- Diseases
- Colorectal cancer
- EU CT number
- 2024-518419-20-00
- EudraCT number
- 2020-003283-10
What you commit to
- Study type: Interventional · Phase 2
- Planned participants: 53
- 4 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
AI-kivonat: who the study is looking for
Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with colorectal cancer that has a BRAF V600E change. The record gives no further details.
- Age
- 18 years or older
- Sex
- All sexes can join
- Biomarker or test result
- BRAF V600E mutation
Read by machine on 9 Nov 2026.
Sites (4)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Aalborg University Hospital | Aalborg | Denmark | Recruiting |
| Rigshospitalet | Copenhagen Oe | Denmark | Recruiting |
| Nordsjaellands Hospital | Hilleroed | Denmark | Recruiting |
| Odense University Hospital | Odense C | Denmark | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.